Page 6 - Read Online
P. 6

20         In vitro antitumor efficacy of Kochia indica extract on human hepatocellular carcinoma cell line
                            with or without 5-fluorouracil
                            Nabil Mohie Abdel-Hamid, Ghada A. Tabl, Yousry E. El-Bolkiny, Walaa O. Zeina
                            Hepatoma Res 2017;3:149-155  http://dx.doi.org/10.20517/2394-5079.2016.50


               21         Advances in the diagnosis and treatment of liver fibrosis
                            Jenny Yeuk-Ki Cheng, Grace Lai-Hung Wong
                            Hepatoma Res 2017;3:156-169  http://dx.doi.org/10.20517/2394-5079.2017.27

               22         Laparoscopic liver resection with lymph node dissection for gallbladder tumors suspected to be
                            T1b/T2 carcinoma
                            Masashi Isetani, Zenichi Morise, Akihiko Horiguchi
                            Hepatoma Res 2017;3:170-177  http://dx.doi.org/10.20517/2394-5079.2017.17

               23         Hepatocellular carcinoma following direct anti-viral for hepatitis C treatment: a report of an
                            Egyptian case series
                            Eman A. Rewisha, Maha M. Elsabaawy, Omar Elshaarawy, Ayat Abdallah, Dalia M. Elsabaawy,
                            Omkolsoum M. Alhaddad
                            Hepatoma Res 2017;3:178-181  http://dx.doi.org/10.20517/2394-5079.2017.18

               24         Transcatheter arterial chemoembolization in recurrent unresectable hepatocellular carcinoma
                            after orthotopic liver transplantation
                            Hasmukh J. Prajapati, Pavan Kavali, Hyun S. Kim
                            Hepatoma Res 2017;3:182-188  http://dx.doi.org/10.20517/2394-5079.2017.25

               25         Surgical strategy for huge and advanced hepatocellular carcinoma in Hong Kong
                            Kenneth S.H. Chok
                            Hepatoma Res 2017;3:189-195  http://dx.doi.org/10.20517/2394-5079.2017.33


               26         Outcomes of emergency and interval hepatectomy for ruptured resectable hepatocellular
                            carcinoma: a single tertiary referral centre experience
                            Andrew Kai Yip Fung, Charing Ching Ning Chong, Kit Fai Lee, John Wong, Yue Sun Cheung,
                            Anthony Kwong Wai Fong, Paul Bo San Lai
                            Hepatoma Res 2017;3:196-204  http://dx.doi.org/10.20517/2394-5079.2017.23


               27         Total regression of hepatocellular carcinoma bone metastases, after liver transplantation, with
                            sorafenib-everolimus
                            Dimitrios Giakoustidis, Athanasios Apostolos Gargavanis, Nikolaos Salveridis, Evangelos Cholongitas,
                            Emmanouil Sinakos, Konstantinos Papapolychroniadis, Vassilios Papanikolaou
                            Hepatoma Res 2017;3:205-208  http://dx.doi.org/10.20517/2394-5079.2017.29


               28         Clinical outcomes of direct-acting antiviral therapy in patients with compensated hepatitis C
                            virus-related cirrhosis
                            Estefania Berge, Ana Arencibia, Elena Otón, Luis Cejas, Silvia Acosta, Francisco Pérez
                            Hepatoma Res 2017;3:209-214  http://dx.doi.org/10.20517/2394-5079.2017.28
   1   2   3   4   5   6   7   8   9   10   11